Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

Name: Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
Published: 2018
License: Public Domain

Ipsen · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

advanced renal cell carcinoma, metastatic renal cell carcinoma, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

Related documents